The EU’s healthcare workforce is in crisis, with health systems described as “underprepared, understaffed, and facing underinvestment.” Since the onset of the pandemic in 2020, healthcare in the EU has been grappling with significant challenges.
Europe has faced numerous healthcare workforce strikes this year. On June 18, thousands of workers from private hospitals, clinics, and retirement homes in France went on strike. Earlier, in February, healthcare professionals in Germany protested in Berlin for better wages.
Pan-European Spanish healthcare real estate investor Healthcare Activos has launched a new investment fund worth €650 million. This is the REIT’s second fund, and will, in contrast to the first fund, be primarily focused on making investments outside of Spain and Portugal. Jorge Guarner, Activos’ President and Founder, tells us more.
Two weeks ago Germany’s cabinet government approved Health Minister Karl Lauterbach’s hospital reform. The current watered-down reform’s key feature is a proposal to move the sector’s reimbursement model away from fee-per-service payments, purportedly to reduce the incentive to overtreat. However, experts tell us the real motivation is still to shut down smaller unspecialised hospitals. Will it succeed in doing so?
German Health Minister Karl Lauterbach’s intention to ban investors from owning outpatient facilities appears to no longer have any realistic chance of being passed. Investors and advisors are consequently gearing up for a flurry of deals in H2 from pent-up demand.
Dr. Volker Wendel founded Sanoptis in 2018 in Switzerland with Carsten Horn. Six years later, the group has grown to more than 400 locations across six European countries. The group was initially backed by PE firm Telemos Capital, who then sold it to Belgian holding company Group Bruxelles Lambert (in 2022). Wendel explains to us how the group is able to add value to ophthalmologists who join the network and shares which areas the group will be focusing on in the coming years.
Germany’s cabinet government has approved Health Minister Karl Lauterbach’s controversial hospital reform. The draft law will now go to the Bundestag, where it is likely to pass. After several months of political wrangling, the final version is focused on moving hospital financing away from DRG-based fee-per-service payments.
French PE firm PAI Partners will become the new owner of Fresenius Vamed’s rehab business. Vamed is currently a subsidiary of German health care conglomerate Fresenius, who will continue to hold a minority stake.
Germany's healthcare landscape is shifting at a speed unseen in a generation, as the government confronts a series of challenges in modernising a healthcare market known for its strong interest and advocacy groups and its resistance to reform.
The UK’s for-profit ophthalmology sector is heating up, with multiple groups likely to come up for sale this year. This is being driven by the long term increase in the amount of cataract surgeries the NHS is outsourcing. Meanwhile deal activity in Germany’s sector is still on pause, due to a decrease in cataract surgery post Covid.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy